Mehwish Zehravi | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Xiumin Wang | Molecular Biology | Women Researcher Award

Posted on by ScienceFather

Prof. Dr. Xiumin Wang | Molecular Biology | Women Researcher Award

Researcher at Feed Research Institute, Chinese Academy of Agricultural Sciences, China

Dr. Wang Xiumin is a distinguished researcher currently serving at the Institute of Feed Research, Chinese Academy of Agricultural Sciences (CAAS). With a profound academic background and extensive research experience in the field of plant pathology and microbial resistance, Dr. Wang has become a leading figure in her field. Over her career, she has focused on microbial resistance, antibacterial peptides, and the development of therapeutic strategies to combat infectious diseases, especially those involving multi-drug resistant pathogens. Dr. Wang’s work has been instrumental in bridging the gap between fundamental microbiology and applied agricultural practices, contributing to the development of feed-related solutions and sustainable agricultural practices. Her research is widely recognized through numerous publications in prestigious scientific journals, where she has co-authored over 80 papers.

Professional Profile

Education:

Dr. Wang Xiumin obtained her Ph.D. in Plant Pathology from Northwest Agriculture & Forestry University in 2006, after completing her Master’s and Bachelor’s degrees at the same institution in 2003 and 2000, respectively. Her academic training equipped her with in-depth knowledge in plant protection and pathology, laying a strong foundation for her career in agricultural sciences and microbiology. Her academic journey enabled her to focus on plant diseases, microbiology, and biotechnology, advancing her research in combating bacterial resistance in agricultural systems.

Professional Experience:

Dr. Wang Xiumin has accumulated extensive professional experience across various prestigious institutions. From 2006 to 2009, she worked as a Postdoctoral Fellow at Beijing Forestry University, engaging in critical research in plant pathology. Between 2009 and 2013, she served as an Assistant Researcher at the Feed Research Institute of CAAS. Since 2013, she has held the position of Associate Researcher at the same institute. In 2019-2020, she visited the School of Chemistry and Molecular Biosciences at the University of Queensland, further enhancing her expertise in molecular biosciences and plant pathology. Throughout her career, Dr. Wang has continually advanced her research while mentoring emerging scientists in her field.

Research Interests:

Dr. Wang’s research interests lie at the intersection of microbial resistance, plant pathology, and feed-related research. Her work primarily focuses on antibacterial peptides, microbial resistance mechanisms, and the development of therapeutic proteins and peptides. She has also contributed to studies on food safety, including the detoxification of mycotoxins, and has explored the therapeutic potential of marine peptides for bacterial infections. Dr. Wang’s research in microbial resistance and peptide-based therapeutics is crucial for advancing sustainable agricultural and clinical practices, particularly in the context of combating drug-resistant pathogens in both animals and humans.

Research Skills:

Dr. Wang Xiumin is highly skilled in a variety of research techniques including molecular biology, microbiology, and biotechnology. She has experience in the design and application of antibacterial peptides, the isolation and characterization of bioactive compounds, and the assessment of microbial resistance mechanisms. Her expertise also extends to advanced techniques in molecular cloning, protein expression, and peptide synthesis. Additionally, Dr. Wang is adept at using in vitro and in vivo models to study the effects of therapeutic peptides and other compounds on microbial infections. Her diverse skill set has been pivotal in advancing her research projects and making significant contributions to agricultural and health sciences.

Awards and Honors:

Dr. Wang Xiumin has received several accolades for her outstanding contributions to the field of plant pathology and microbiology. She has been recognized for her innovative research in microbial resistance and peptide-based therapeutics, receiving awards from various scientific and agricultural bodies in China. Her significant publications in high-impact journals such as Science of the Total Environment, Journal of Medicinal Chemistry, and Food Chemistry have cemented her reputation as a leading researcher in her field. Additionally, her collaborative work with international research institutes has earned her several fellowships, including her research visit to the University of Queensland, further acknowledging her impact on global agricultural science and medical microbiology.

Conclusion

Dr. Wang Xiumin demonstrates a strong and well-rounded research profile, with impressive publications and a proven ability to address complex issues in plant pathology and antimicrobial resistance. His work is highly relevant and impactful in agricultural and biomedical fields. His contributions place him as a strong candidate for the Excellence in Research Award. Expanding his industry collaborations and mentoring roles would elevate his profile further, making him an even more influential figure in his field.

Publication Top Notes

  1. Application of Lactobacillus plantarum and Pediococcus lactis on Lipid Metabolism, Anti-Inflammatory, and Fecal Microbiota in Cats
    • Authors: Shukun Liang, Xinshu Gu, Jintao Sun, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
    • Year: 2024
    • DOI: 10.3390/microorganisms12122446
  2. Application of Network Pharmacology, Molecular Docking, and In Vitro Experimental Evaluation to Decipher the Anti-Inflammatory Mechanisms of Cirsium japonicum
    • Authors: Jiaxue Wang, Hui Tao, Zhenlong Wang, Wei An, Ya Zhao, Bing Han, Jinquan Wang, Xiuzhu Sun, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/app14219687
  3. Simultaneous Degradation of AFB1 and ZEN by CotA Laccase from Bacillus subtilis ZJ-2019-1 in the Mediator-Assisted or Immobilization System
    • Authors: Boquan Gao, Wei An, Jianwen Wu, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Zhenlong Wang, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/toxins16100445
  4. Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies
    • Authors: Wei An, Ting Li, Xinya Tian, Xiaoxin Fu, Chunxiao Li, Zhenlong Wang, Jinquan Wang, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/ijms251910520
  5. Bacillus subtilis Simultaneously Detoxified Aflatoxin B1 and Zearalenone
    • Authors: Jianwen Wu, Zhenlong Wang, Wei An, Boquan Gao, Chunxiao Li, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang, Huanrong Li
    • Year: 2024
    • DOI: 10.3390/app14041589
  6. The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    • Authors: Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/microorganisms12010091
  7. Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets
    • Authors: Zhenlong Wang, Zonghao Lv, Tibor Czabany, Veronika Nagl, Rudolf Krska, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/toxins16010003
  8. The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
    • Authors: Bing Han, Peng Zhao, Shukun Liang, Zhenlong Wang, Hui Tao, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/app13179713
  9. A Screening Model of Antibacterial Agents Based on Escherichia coli Cell-Division Protein
    • Authors: Qiuyu Fan, Jianwen Wu, Bolin Xi, Chunxiao Li, Xiumin Wang, Huanrong Li
    • Year: 2023
    • DOI: 10.3390/app13074493
  10. Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources
    • Authors: ChunMing Xu, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, Xiumin Wang
    • Year: 2022
    • DOI: 10.3390/antibiotics11111535

 

Elisson Romanel | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Elisson Romanel | Molecular Biology | Best Researcher Award

Professor Researcher at School of Engineering of Lorena, Brazil.

Dr. Elisson Romanel is a prominent researcher and Professor of Functional Genomics and Plant Biotechnology at the School of Engineering of Lorena, University of São Paulo, Brazil. He holds a Ph.D. in Biological Sciences, with a focus on plant development and genomics, earned from the Federal University of Rio de Janeiro. His postdoctoral research included significant collaborations at renowned institutions, such as Iowa State University and the Universidad Nacional Autónoma de México. Dr. Romanel founded the Plant Genomics and Bionergy Laboratory, focusing on the genetic and metabolic pathways in sugarcane and related grasses to enhance biomass utilization in biorefineries. He has secured various grants and published extensively in respected journals, contributing valuable insights into plant genomics, flowering time regulation, and lignocellulosic metabolism. Additionally, he has supervised numerous graduate students, shaping the next generation of scientists in the field of plant biotechnology.

Profile:

Education

Dr. Elisson Romanel completed his undergraduate studies in Biological Sciences at the Federal University of Juiz de Fora in Brazil, earning his degree in 2004. He then pursued his Ph.D. at the Federal University of Rio de Janeiro, where he was awarded a sandwich Ph.D. in February 2010. During this time, he conducted research at prominent institutions, including the University of Wisconsin-Madison in the USA and the École Normale Supérieure de Lyon in France, under the supervision of Dr. Marcio Alves Ferreira. Following his Ph.D., Dr. Romanel continued his academic journey with a postdoctoral fellowship at the same university, focusing on virus, small RNAs, and transposons. His research also involved collaboration with esteemed researchers at the Universidad Nacional Autónoma de México, where he studied the Flowering Time Gene Regulatory Network. Dr. Romanel’s extensive educational background laid a solid foundation for his current role as a professor in Functional Genomics and Plant Biotechnology.

Professional Experiences 

Dr. Elisson Romanel is a distinguished researcher and educator currently serving as a Professor of Functional Genomics and Plant Biotechnology at the School of Engineering of Lorena, University of São Paulo (EEL/USP) in Brazil. He founded the Plant Genomics and Bionergy Laboratory (PGEMBL) in 2016, focusing on gene prospecting related to biomass control and lignocellulosic metabolism, particularly in sugarcane and related grasses. Dr. Romanel has conducted significant postdoctoral research at prestigious institutions, including the Federal University of Rio de Janeiro and Iowa State University, where he collaborated with renowned scientists in plant genomics and biotechnology. His work encompasses bioinformatics, gene cloning, and plant transformation, contributing to the understanding of plant development and flowering time regulatory networks. He has actively supervised several graduate students and served on editorial boards for prominent journals, further showcasing his commitment to advancing research in plant sciences and biotechnology.

Research Interests

Dr. Elisson Romanel’s research interests lie at the intersection of functional genomics and plant biotechnology, with a strong focus on the fundamental and applied aspects of plant development. His work primarily investigates gene regulatory networks and the molecular mechanisms that govern flowering time in plants such as Arabidopsis, eucalyptus, and cotton. He has extensively studied small RNAs, transposons, and the biosynthesis pathways of hemicellulose in sugarcane, aiming to enhance the utilization of plant biomass for biorefinery applications. Dr. Romanel is particularly interested in the evolutionary aspects of plant genes and their roles in lignocellulosic metabolism, contributing to sustainable agricultural practices and industrial biotechnology. Through his research at the Plant Genomics and Bionergy Laboratory (PGEMBL), he aims to uncover the genetic bases of traits that improve biomass recalcitrance and enhance bioenergy production, ultimately addressing global challenges in energy sustainability and food security.

Research skills 

Dr. Elisson Romanel possesses a diverse and comprehensive skill set in research, primarily focusing on functional genomics and plant biotechnology. His expertise includes bioinformatics, gene cloning, plant transformation, and structural and functional genomics analysis, particularly in species such as Arabidopsis, eucalyptus, and cotton. Dr. Romanel’s proficiency in transcriptome profiling and gene expression analysis allows him to investigate complex biological processes, such as flowering induction and biomass development. His ability to conduct multidisciplinary research is exemplified by collaborations with renowned laboratories and institutions worldwide, including those in the United States and Mexico. Furthermore, he has demonstrated strong leadership and mentorship skills through his supervision of numerous graduate students, guiding them in their academic and research pursuits. With a robust publication record and experience in securing research funding, Dr. Romanel effectively translates his research findings into practical applications, contributing significantly to advancements in agricultural biotechnology and plant sciences.

Award and Recognition 

Dr. Elisson Romanel is a distinguished researcher in the field of plant biotechnology and functional genomics, recognized for his significant contributions to the understanding of plant development and biomass utilization. He has secured multiple grants from esteemed funding bodies, including CAPES and FAPESP, showcasing his ability to attract substantial financial support for research initiatives. His work has led to numerous publications in reputable journals, highlighting his innovative research on gene expression and metabolic pathways in crops like sugarcane and eucalyptus. Dr. Romanel’s editorial roles on the boards of Brazilian Journal of Botany, BMC Genomics, and Frontiers in Plant Science reflect his expertise and standing in the scientific community. Furthermore, his leadership in founding the Plant Genomics and Bionergy Laboratory at the School of Engineering of Lorena, University of São Paulo, underscores his commitment to advancing research and training future scientists in the field.

Conclusion

Dr. Elisson Romanel’s comprehensive educational background, extensive research experience, leadership in establishing a laboratory, and significant contributions to plant biotechnology position him as a strong candidate for the Best Researcher Award. His ability to innovate and lead in important research areas related to plant genomics and bioenergy, combined with his dedication to mentoring the next generation of scientists, underscores his value to the scientific community. With some focus on interdisciplinary collaboration and public engagement, Dr. Romanel could further enhance his contributions to science and society.

Publication Top Notes
  1. SacEXP32 sugarcane expansin gene expression increases cell size and improves biomass digestibility
    • Authors: Mira, W., Heinz, O., Gonçalvez, A., Ferraz, A., da Franca Silva, T.
    • Year: 2024
    • Journal: Journal of Plant Biochemistry and Biotechnology
    • Volume/Issue/Page: 33(3), pp. 313–325
  2. Plant age-dependent dynamics of annatto pigment (bixin) biosynthesis in Bixa orellana
    • Authors: de Godoy Machado, K.L., Faria, D.V., Duarte, M.B.S., Otoni, W.C., Nogueira, F.T.S.
    • Year: 2024
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 75(5), pp. 1390–1406
  3. Advances in Tissue Culture and Transformation Studies in Non-model Species: Passiflora spp. (Passifloraceae)
    • Authors: Otoni, W.C., Soares, J.R., Souza, C.S., Nogueira, F.T.S., Silva, M.L.C.
    • Year: 2024
    • Journal: Methods in Molecular Biology
    • Volume/Issue/Page: 2827, pp. 207–222
  4. Editorial: System biology to regulatory grids: new tools and clues aimed at improving plant evolutionary-developmental (Evo-Devo) biology
    • Authors: Romanel, E., DePaoli, H.C., Brito, M.D.S.
    • Year: 2024
    • Journal: Frontiers in Plant Science
    • Volume/Issue/Page: 15, 1380569
  5. Erratum: Analysis of the PEBP gene family and identification of a novel FT orthologue in sugarcane
    • Authors: Venail, J., Da Silva Santos, P.H., Manechini, J.R., Pinto, L., Jackson, S.D.
    • Year: 2022
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 73(12), pp. 4266
  6. Analysis of the PEBP gene family and identification of a novel FLOWERING LOCUS T orthologue in sugarcane
    • Authors: Venail, J., Da Silva Santos, P.H., Manechini, J.R., Pinto, L., Jackson, S.D.
    • Year: 2022
    • Journal: Journal of Experimental Botany
    • Volume/Issue/Page: 73(7), pp. 2035–2049
  7. Expression of Melocactus glaucescens SERK1 sheds new light on the mechanism of areolar activation in cacti
    • Authors: Torres-Silva, G., Correia, L.N.F., Koehler, A.D., Specht, C.D., Otoni, W.C.
    • Year: 2021
    • Journal: Plant Cell, Tissue and Organ Culture
    • Volume/Issue/Page: 147(3), pp. 437–451
  8. Selection and validation of reference genes by RT-qPCR under photoperiodic induction of flowering in sugarcane (Saccharum spp.)
    • Authors: da Silva Santos, P.H., Manechini, J.R.V., Brito, M.S., Jackson, S., Pinto, L.R.
    • Year: 2021
    • Journal: Scientific Reports
    • Volume/Issue/Page: 11(1), 4589
  9. Transcriptome Analysis of Melocactus glaucescens (Cactaceae) Reveals Metabolic Changes During in vitro Shoot Organogenesis Induction
    • Authors: Torres-Silva, G., Correia, L.N.F., Batista, D.S., Specht, C.D., Otoni, W.C.
    • Year: 2021
    • Journal: Frontiers in Plant Science
    • Volume/Issue/Page: 12, 697556
  10. Transcriptomic Analysis of Changes in Gene Expression During Flowering Induction in Sugarcane Under Controlled Photoperiodic Conditions
  • Authors: Manechini, J.R.V., Santos, P.H.D.S., Romanel, E., Pinto, L.R., Vicentini, R.
  • Year: 2021
  • Journal: Frontiers in Plant Science
  • Volume/Issue/Page: 12, 635784

 

 

Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Attending physician, Department of Endocrinology, Children’s Hospital of Nanjing Medical University, China.

Yuanyuan Li is a dedicated pediatrician and researcher with a Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University. Her research focuses on pediatric metabolic and kidney diseases, with particular interest in metabolic dysfunction-associated fatty liver disease. Li has published extensively as the first or corresponding author in prestigious journals, contributing valuable insights into liver disease, kidney dysfunction, and related metabolic conditions. She has led significant research projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her clinical expertise is recognized through awards such as the Best Resident Physician Award and the Ruihua First-Class Scholarship from Nanjing Children’s Hospital. Li’s research holds the potential for a positive impact on pediatric healthcare, while her leadership in both clinical and research settings highlights her as a rising scholar in her field.

Profile:

Education

Yuanyuan Li has a solid educational foundation in Clinical Medicine, specializing in Pediatrics. She earned her Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University in 2020, under the supervision of Professor Zhanjun Jia. Her doctoral research focused on pediatric diseases, with a particular emphasis on metabolic and kidney disorders. Prior to her Ph.D., Li completed her Master of Science in Clinical Medicine (Pediatrics) at the same university in 2017, guided by Professor Aihua Zhang. During this time, she honed her clinical and research skills, gaining in-depth knowledge of pediatric healthcare. Li began her academic journey with a Bachelor of Science in Clinical Medicine (Pediatrics), which she completed in 2015. Her comprehensive education, grounded in both theoretical knowledge and practical experience, has equipped her with the expertise to conduct impactful research and provide specialized pediatric care, particularly in the fields of metabolism and kidney disease.

Professional Experience

Yuanyuan Li has extensive professional experience as a pediatrician at Nanjing Children’s Hospital, where she has been serving since October 2020. In this role, she is responsible for the specialized diagnosis and treatment of pediatric diseases, with a particular focus on metabolic and kidney-related conditions. Her clinical expertise is complemented by her active involvement in epidemiological research, where she investigates the occurrence of pediatric diseases and explores related pathogenesis. Li’s dedication to integrating clinical practice with research allows her to translate scientific findings into improved patient care. Additionally, she has led several research projects funded by prestigious institutions such as the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her role as a project head in these research initiatives reflects her leadership abilities and commitment to advancing knowledge in the field of pediatric health, particularly in metabolic disorders and kidney diseases.

Research Interests

Yuanyuan Li’s research interests focus on pediatric metabolic and kidney diseases, with a particular emphasis on understanding metabolic dysfunction and its implications. Her work explores the characteristics and pathogenesis of metabolic dysfunction-associated fatty liver disease, delving into the intricate mechanisms that connect metabolic disorders with liver damage. Additionally, she investigates kidney diseases, studying conditions like acute kidney injury and renal fibrosis, especially in pediatric populations. Yuanyuan is also interested in oxidative stress and its role in metabolic and infectious diseases, examining how factors like birthweight influence disease development. Her research aims to uncover the molecular pathways involved in these conditions, with the ultimate goal of improving diagnosis, treatment, and prevention strategies. By combining clinical and basic research, she contributes to a deeper understanding of metabolic diseases, hoping to make a significant impact on pediatric healthcare and public health outcomes.

Award and Recognition

Yuanyuan Li has received multiple prestigious awards and recognitions throughout her academic and professional career. She was honored with the Best Resident Physician Award at Nanjing Children’s Hospital in 2021, a testament to her outstanding clinical expertise and dedication to pediatric care. That same year, she earned the Ruihua First-Class Scholarship, further acknowledging her academic excellence and commitment to research. Yuanyuan has led several significant research projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting her leadership and innovation in the field of metabolic and kidney diseases. Her numerous publications in high-impact journals solidify her reputation as an emerging leader in clinical and basic research. These accolades reflect not only her individual achievements but also her contribution to advancing pediatric medicine and metabolic disease research on a national and international level.

Conclusion

Yuanyuan Li’s academic achievements, research contributions, and clinical excellence position her as a strong contender for the Research for Best Scholar Award. Her focus on pediatric metabolic and kidney diseases addresses critical healthcare challenges, and her leadership in securing research funding demonstrates her potential for sustained scholarly impact. However, further development in international collaboration, mentorship, and research diversification could enhance her candidacy and future contributions to the academic community.

Publication Top Notes

    1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly ApproachAuthors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.

      Year: 2024

      Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱

    2. An Overview of Pharmacological Activities and Beneficial Effects of 3-HydroxyflavoneAuthors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.

      Year: 2024

      Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊

    3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability StudiesAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈

    4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South IndiaAuthors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega. 🌊💧

    5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin TabletsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊

    6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticalsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖

    7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves MucilageAuthors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.

      Year: 2021

      Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊

    8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLCAuthors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.

      Year: 2020

      Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬

    9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLCAuthors: Ajitha, A., Sujatha, K., Abbulu, K.

      Year: 2019

      Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸

    10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational StudiesAuthors: Deepa, S., Sujatha, K., Velmurugan, D.

      Year: 2019

      Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Posted on by ScienceFather

Dr. Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Assistant Professor of Mashhad university of Medical Sciences, Iran.

Dr. Ehsan Saburi is an Assistant Professor at the School of Medicine, Mashhad University of Medical Sciences, specializing in Molecular Medicine. He holds a Ph.D. and has contributed significantly to research in areas such as stem cell therapy, COVID-19, and the molecular mechanisms of various diseases. Dr. Saburi has led numerous research projects, exploring the genetic and molecular aspects of health conditions like COVID-19, cancer, and autoimmune disorders. His work includes the investigation of gene polymorphisms, the therapeutic potential of cell therapy, and the effects of natural compounds on disease progression. Dr. Saburi’s research has been published in high-impact journals, demonstrating his commitment to advancing medical knowledge. His expertise in molecular medicine and his dedication to innovative research make him a strong candidate for the Best Researcher Award.

Profile
Education

Dr. Ehsan Saburi is an accomplished academic with a strong foundation in Molecular Medicine. He earned his Doctor of Philosophy (Ph.D.) in this specialized field, reflecting his deep commitment to advancing medical science. His educational journey is marked by rigorous training and research, equipping him with a profound understanding of molecular mechanisms and their applications in medicine. Dr. Saburi’s academic background is further enriched by his involvement in various research projects at the Mashhad University of Medical Sciences, where he continues to explore the frontiers of medical research. His education has provided him with the skills and knowledge necessary to contribute significantly to the scientific community, particularly in the areas of stem cell research, genetic studies, and the development of innovative medical therapies. Dr. Saburi’s educational achievements underscore his dedication to excellence in both teaching and research, making him a respected figure in his field.

Professional Experience

Dr. Ehsan Saburi is an accomplished Assistant Professor at Mashhad University of Medical Sciences, specializing in Molecular Medicine. With a Ph.D. in the same field, he has played a pivotal role in various research projects, particularly those focusing on the molecular mechanisms of diseases, stem cell therapy, and the impact of genetic polymorphisms on health outcomes. His professional experience is marked by leadership in numerous high-impact studies, including investigations into COVID-19, stem cell differentiation, and the protective effects of natural compounds on organ systems. Dr. Saburi has been instrumental in advancing research in molecular medicine through his extensive work on genetic factors influencing disease severity and innovative therapeutic approaches. His contributions to the academic community are further evidenced by his numerous publications in reputable journals and his active involvement in ongoing research projects aimed at improving health outcomes through molecular and genetic insights.

Research Interest

Dr. Ehsan Saburi’s research interests lie at the intersection of molecular medicine and regenerative medicine, with a particular focus on the therapeutic potential of stem cells and the molecular mechanisms underlying various diseases. His work extensively explores the use of adipose-derived mesenchymal stem cells (AD-hMSCs) in tissue regeneration, particularly in the context of osteogenic and chondrogenic differentiation. Dr. Saburi is also deeply involved in studying the genetic and molecular pathways related to chronic diseases, including cancer and autoimmune disorders. His recent projects have investigated the effects of various bioactive compounds, such as melatonin and curcumin, on mitigating disease symptoms and improving patient outcomes. Additionally, Dr. Saburi’s research includes examining the genetic factors that influence the severity of infectious diseases like COVID-19, aiming to contribute to the development of more effective treatments and vaccines. His multidisciplinary approach positions him at the forefront of translational medicine and therapeutic innovation.

Research Skills

Dr. Ehsan Saburi, an Assistant Professor of Molecular Medicine at Mashhad University of Medical Sciences, demonstrates extensive expertise in advanced molecular and cellular research. His skills encompass a wide range of scientific techniques, including genetic manipulation, stem cell research, and biochemical analysis. Dr. Saburi has led numerous research projects, particularly focusing on the genetic and molecular mechanisms underlying diseases such as cancer, COVID-19, and neurodegenerative disorders. His proficiency in designing and executing complex experiments is evidenced by his successful investigation of various signaling pathways, gene polymorphisms, and therapeutic effects of natural compounds. Additionally, Dr. Saburi is skilled in the use of bioinformatics tools for data analysis and interpretation, contributing to his ability to publish in high-impact journals. His collaborative approach and ability to manage multidisciplinary research teams further highlight his research capabilities, making him a valuable asset in the field of molecular medicine.

Awards and Recognition

Dr. Ehsan Saburi, an accomplished Assistant Professor at Mashhad University of Medical Sciences, has garnered significant recognition for his contributions to molecular medicine. His extensive research on stem cell therapies, COVID-19, and the molecular mechanisms underlying various diseases has earned him numerous accolades. Dr. Saburi’s innovative work on the protective effects of melatonin and curcumin in disease models has been widely acknowledged in the scientific community. He has received several prestigious awards for his groundbreaking research, including the Best Researcher Award from Mashhad University. His publications in high-impact journals and his involvement in pioneering research projects have further solidified his reputation as a leading scientist. Dr. Saburi’s commitment to advancing medical science continues to be recognized through various honors and awards, underscoring his impact on the field and his dedication to improving human health.

Conclusion

Dr. Ehsan Saburi is a highly capable and dedicated researcher with significant contributions to molecular medicine and COVID-19 research. His extensive research activities, leadership in numerous projects, and commitment to advancing medical science make him a strong candidate for the Best Researcher Award. However, to enhance his candidacy further, focusing on the impact of his publications, fostering international collaborations, and pursuing more innovative research avenues would be beneficial.

Publications Top Notes

  1. Title: Advances and challenges of the cell-based therapies among diabetic patients
    Authors: Raoufinia, R., Rahimi, H.R., Saburi, E., Moghbeli, M.
    Journal: Journal of Translational Medicine
    Year: 2024
    Citations: 1
  2. Title: Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies
    Authors: Raoufinia, R., Arabnezhad, A., Keyhanvar, N., Namdar, A.B., Rahimi, H.R.
    Journal: Molecular Biology Reports
    Year: 2024
  3. Title: Hematological changes due to malaria – An update
    Authors: Naser, R.H., Rajaii, T., Farash, B.R.H., Sadabadi, F., Saburi, E.
    Journal: Molecular and Biochemical Parasitology
    Year: 2024
  4. Title: Apoptotic effects of biodentine, calcium-enriched mixture (CEM) cement, ferric sulfate, and mineral trioxide aggregate (MTA) on human mesenchymal stem cells isolated from the human pulp of exfoliated deciduous teeth
    Authors: Nazemi Salman, B., Mohebbi Rad, M., Saburi, E.
    Journal: Minerva Dental and Oral Science
    Year: 2024
  5. Title: Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
    Authors: Raoufinia, R., Rahimi, H.R., Keyhanvar, N., Foroudi, S., Saburi, E.
    Journal: Stem Cell Reviews and Reports
    Year: 2024
    Citations: 1
  6. Title: Role of microRNAs in tumor progression by regulation of kinesin motor proteins
    Authors: Nasimi Shad, A., Fanoodi, A., Maharati, A., Forouzanfar, F., Moghbeli, M.
    Journal: International Journal of Biological Macromolecules
    Year: 2024
  7. Title: Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development
    Authors: Saadh, M.J., Bazghandi, B., Jamialahmdi, H., Esmaeili, S.-A., Saburi, E.
    Journal: European Journal of Pharmacology
    Year: 2024
  8. Title: Synthesis of bone biocompatible implants using human adipose-derived mesenchymal stem cells (hADMSCs) and PCL/laminin scaffold substrate
    Authors: Zeydari, D., Karimi, E., Saburi, E.
    Journal: Iranian Journal of Basic Medical Sciences
    Year: 2024
    Citations: 2
  9. Title: Genetic landscape of hearing loss in prelingual deaf patients of eastern Iran: Insights from exome sequencing analysis
    Authors: Alerasool, M., Eslahi, A., Vona, B., Niknezhad, H.T., Mojarrad, M.
    Journal: Clinical Genetics
    Year: 2024
  10. Title: Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics
    Authors: Raoufinia, R., Rahimi, H.R., Abbaszadeh, M., Khazaei, M., Avan, A.
    Journal: Current Pharmaceutical Design
    Year: 2024

 

Jaafar Abduo | Prosthodontics | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jaafar Abduo | Prosthodontics | Best Researcher Award

Prosthodontist at Melbourne Dental School, Australia.

Dr. Jaafar Abduo is an Associate Professor of Prosthodontics at Melbourne Dental School, University of Melbourne. He holds a PhD from the University of Western Australia and has extensive experience in clinical dentistry. His research focuses on digital workflows, implant prosthodontics, and the evaluation of modern dental manufacturing techniques. Dr. Abduo has published over 90 peer-reviewed papers and has a significant impact on the field, with an h-index of 30 and more than 4,600 citations. He collaborates with leading dental companies and has been awarded multiple national and international grants. Additionally, he serves on various academic and professional committees, contributing to research ethics, curriculum development, and continuing education. Dr. Abduo’s work has been presented at major international conferences, and his innovations have influenced both academic research and clinical practices in prosthodontics globally.

Profile
Education

Dr. Jaafar Abduo’s educational background is distinguished by his extensive training in dentistry and prosthodontics. He earned his Doctor of Philosophy (PhD) by publication from the University of Western Australia in 2016, which reflects his significant contributions to dental research. Prior to this, he completed the Doctor of Clinical Dentistry in Prosthodontics (DClinDent) at the University of Otago, Dunedin, New Zealand, in 2010, underscoring his specialized expertise in prosthodontics. His journey began with a Bachelor of Dental Surgery with credit from the University of Otago in 2004. Additionally, he achieved Membership of the Royal Australasian College of Dental Surgeons in Prosthodontics (MRACDS Pros) through examination in Sydney, Australia, in 2011. This robust educational foundation has equipped Dr. Abduo with the knowledge and skills necessary to advance the field of dental prosthetics.

Professional Experience

Dr. Jaafar Abduo is an accomplished prosthodontist and Associate Professor at the Melbourne Dental School, University of Melbourne. Since January 2020, he has held the position of Associate Professor (Level D) in Prosthodontics, where he also serves as the Convenor for the Doctor of Clinical Dentistry (Prosthodontics) program and the Postgraduate Diploma in Clinical Dentistry (Implants). Dr. Abduo’s career at the Melbourne Dental School began in 2013 as a Senior Lecturer (Level C) in Prosthodontics. Alongside his academic roles, he has been a practicing specialist prosthodontist in private practice since 2011. Dr. Abduo’s expertise spans removable prosthodontics, complex rehabilitation, and implant prosthodontics, and he is actively involved in both teaching and research. His work is well-regarded, with numerous peer-reviewed publications and significant contributions to advancing dental education and clinical practice.

Research Interest

Dr. Jaafar Abduo’s research interests are centered around advancing prosthodontics, with a particular focus on digital dentistry and modern manufacturing techniques. He explores the development and evaluation of digital workflows for diagnostics, conventional, removable, and implant prosthodontics, aiming to improve accuracy and efficiency in dental treatments. His work also includes randomized controlled trials to assess the clinical outcomes of materials such as monolithic zirconia and metal-ceramic implant crowns. Additionally, Dr. Abduo is interested in optimizing digital scanning methods for natural teeth, soft tissue, and implants. His biomechanical studies on implant and natural tooth comparisons, along with his research on the durability of dental prosthetics, contribute to enhancing the quality and longevity of dental restorations. Through his research, Dr. Abduo seeks to bridge the gap between clinical practice and technological advancements, ultimately improving patient outcomes in prosthodontics.

Research Skills

Dr. Jaafar Abduo possesses a comprehensive set of research skills that have greatly contributed to the field of prosthodontics. His expertise lies in digital dentistry, particularly in developing and optimizing digital workflows for various prosthodontic procedures, including implant and removable prosthodontics. He is proficient in conducting randomized controlled trials and biomechanical evaluations, ensuring the clinical efficacy and durability of dental materials and techniques. Dr. Abduo’s collaboration with industry leaders showcases his ability to bridge academic research with practical applications, enhancing dental treatment outcomes. His supervisory experience, guiding numerous Doctor of Clinical Dentistry and postgraduate students, demonstrates his mentorship skills and commitment to advancing dental education. Additionally, Dr. Abduo has secured multiple research grants, highlighting his capability in securing funding and managing large-scale projects. His strong publication record, with a high h-index and numerous citations, underscores his ability to disseminate research findings effectively and contribute to the broader scientific community.

Awards and Recognition

Dr. Abduo has received several prestigious awards and grants, including the F. A. Kernott Early Career Researcher Award and various grants from the Australian Dental Research Foundation and international sources. His high h-index and citation count further demonstrate his impact and recognition in the field.

Conclusion

Dr. Jaafar Abduo is a highly deserving candidate for the Research for Best Researcher Award. His extensive research contributions, collaborative efforts, and impactful projects in prosthodontics reflect his dedication to advancing dental science. His work has both national and international significance, making him a prominent figure in the field of dental research.

Publications Top Notes

  • “Muscle and joint mechanics during maximum force biting following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2024
    • Citations: 0
  • “Effect of prefabricated immediate interim prosthesis design and insertion workflow on seating accuracy on implants placed via static computer-assisted implant surgery: A cross-sectional in vitro study”
    • Authors: Abduo, J., Lau, D.
    • Year: 2024
    • Citations: 0
  • “Influence of Implant Adjacent Teeth on the Accuracy of Digital Impression”
    • Authors: Abduo, J., El-Haddad, H.
    • Year: 2024
    • Citations: 0
  • “Seating accuracy of removable partial denture frameworks fabricated by different digital workflows in comparison to conventional workflow”
    • Authors: Korkes, A., Jomaa, J., Kavouris, A., Law, K.H.J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “Effect of pilot-guided implant placement concept on the accuracy of osteotomy preparation and implant placement”
    • Authors: Sharma, S., Tan, E., Tran, B., Teo, J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “The Effect of Various Lasers on the Bond Strength Between Orthodontic Brackets and Dental Ceramics: A Systematic Review and Meta-Analysis”
    • Authors: Mosaddad, S.A., Abduo, J., Zakizade, M., Tebyaniyan, H., Hussain, A.
    • Year: 2024
    • Citations: 2
  • “Accuracy of Static Computer-Assisted Implant Placement in Posterior Edentulous Areas with Different Levels of Tooth-Support by Novice Clinicians”
    • Authors: Abduo, J., Lau, D.
    • Year: 2023
    • Citations: 0
  • “Kinematics of the jaw following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2023
    • Citations: 3
  • “Marginal Accuracy of Monolithic and Veneered Zirconia Crowns Fabricated by Conventional and Digital Workflows”
    • Authors: Abduo, J., Ho, G., Centorame, A., Le, P., Ngo, C.
    • Year: 2023
    • Citations: 3
  • “Measuring tooth movement with treatment using the Dahl principle: An observational study”
    • Authors: Bhai, K., Judge, R., Abduo, J., Palamara, J.
    • Year: 2023
    • Citations: 1

Mariela Gironacci | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Mariela Gironacci | Molecular Biology | Best Researcher Award

Professor at University of Buenos Aires , Argentina.

Dr. Mariela Mercedes Gironacci is a distinguished Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University. With a Ph.D. from the University of Buenos Aires and a career spanning over two decades, Dr. Gironacci has made significant contributions to hypertension research. Her work focuses on the Mas receptor and its role in anti-inflammatory and antihypertensive responses. She has led multiple research projects funded by CONICET and other national and international bodies. Dr. Gironacci has received numerous awards, including the Braun Menéndez Award and the Prof. Dr. Luis Moledo Award, recognizing her excellence in hypertension research. She is an active member of professional societies, serves on editorial boards, and has delivered invited lectures globally. Her research impact is evident in her extensive publications and her leadership in advancing our understanding of the renin-angiotensin system.

Profile
Education

Dr. Mariela Mercedes Gironacci holds a distinguished educational background in the field of pharmacology and biochemistry. She earned her Bachelor’s degree in Pharmacy from the National University of Córdoba, Argentina, in 1988. Building upon this foundation, she pursued advanced studies at the University of Buenos Aires, where she completed her Ph.D. in 1999. Her doctoral research contributed significantly to the understanding of the renin-angiotensin system, particularly in relation to hypertension. Dr. Gironacci’s academic journey reflects a strong commitment to advancing knowledge in her field, laying the groundwork for her subsequent research and professional achievements. Her education has equipped her with the expertise necessary to make substantial contributions to pharmacology and biochemistry, particularly in hypertension and cardiovascular research.

Professional Experience

Dr. Mariela Mercedes Gironacci is an esteemed Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University, where she has served since March 2023. Her academic career began as an Instructor in 1991, progressing to Assistant Professor (1996-2008) and then Associate Professor (2008-2023) before her current role. Concurrently, Dr. Gironacci has been a Principal Investigator at the National Council of Scientific and Technical Research (CONICET) since December 2019. Her research focuses on hypertension and cardiovascular health, particularly the Mas receptor’s role in antihypertensive responses. Her leadership extends to serving on various editorial boards, including Hypertension and the Journal of the Argentinian Society of Hypertension, and she has held significant positions in professional societies, including the Inter-American Society of Hypertension. Her extensive experience in teaching, research, and leadership underscores her significant contributions to the field.

Research Interest

Dr. Mariela Mercedes Gironacci’s research primarily focuses on the role of the renin-angiotensin system (RAS) in cardiovascular health, particularly through the study of angiotensin-(1-7) and its associated Mas receptor. Her work delves into the antihypertensive and cardioprotective properties of angiotensin-(1-7), exploring its interactions with other receptors and its impact on conditions such as hypertension and Alzheimer’s disease. Dr. Gironacci’s research also examines the receptor’s involvement in inflammatory responses and its potential therapeutic targets for hypertension and neurodegenerative disorders. She is engaged in elucidating the mechanisms behind Mas receptor trafficking and its role in regulating blood pressure and cardiac function. Her contributions extend to investigating the biological responses triggered by receptor interactions, aiming to advance the understanding and treatment of hypertension and related cardiovascular diseases.

Research Skills

Dr. Mariela Mercedes Gironacci demonstrates exceptional research skills through her extensive work on the Mas receptor and its role in cardiovascular health. Her expertise encompasses a deep understanding of receptor regulation and trafficking, particularly in relation to antihypertensive responses. Dr. Gironacci has led pioneering studies on the depressor axis of the renin-angiotensin system, focusing on the receptor Mas and its interactions with other receptors. Her ability to design and execute complex research projects is evident in her numerous high-impact publications and successful grant applications. She employs advanced methodologies including receptor heteromerization studies, FRET approaches, and molecular modeling to unravel the mechanisms underlying hypertension and cardiovascular diseases. Additionally, her role as an editor and reviewer for leading journals underscores her commitment to maintaining rigorous research standards and advancing the field of cardiovascular pharmacology.

Awards and Recognition

Dr. Gironacci has received numerous awards for her contributions to hypertension research, including prestigious recognitions such as the Braun Menendez Award, the Luis Moledo Award, and the Prof. Dr. C. Taquini Award. These accolades reflect her excellence in research and her impact on the field. Her recognition extends to both national and international levels, highlighting her standing as a leading researcher in her field.

Conclusion

Dr. Mariela Mercedes Gironacci’s extensive research contributions, impactful projects, and numerous awards position her as a strong candidate for the Best Researcher Award. Her work has advanced scientific understanding of hypertension and related conditions, with significant implications for both clinical practice and public health. Her dedication to research, collaborative efforts, and recognition by prestigious institutions underscore her outstanding achievements in the field.

Publications Top Notes

  1. Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension
    • Authors: J. Minetto, M.B. Cuello, F.P. Dominici, W.G. Espeche, M.M. Gironacci
    • Year: 2024
  2. Unraveling the crosstalk between renin-angiotensin system receptors
    • Authors: M.M. Gironacci, E. Bruna-Haupt
    • Year: 2024
  3. Valproate decreases transgenerationally blood pressure by affecting thyrotropin-releasing hormone promoter DNA methylation and gene expression in spontaneously hypertensive rat
    • Authors: M.S. Landa, M.L. Schuman, M. Aisicovich, S.I. García, C.J. Pirola
    • Year: 2024
  4. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli
    • Authors: C. Berdasco, A. Pinto, M.G. Blake, J. Gironacci, J. Goldstein
    • Year: 2023
    • Citations: 1
  5. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, M. Nuñez, M.M. Gironacci
    • Year: 2023
    • Citations: 12
  6. Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D
    • Authors: M.G. Silva, F. Inserra, J. Mariani, W. Manucha, M.M. Gironacci
    • Year: 2023
    • Citations: 1
  7. Mas receptor endocytosis and signaling in health and disease
    • Authors: N.L. Rukavina Mikusic, M.M. Gironacci
    • Year: 2023
  8. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19
    • Authors: M.G. Silva, G.R. Corradi, J.I. Pérez Duhalde, W.G. Espeche, M.M. Gironacci
    • Year: 2022
    • Citations: 6
  9. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, G.R. Guman, M.M. Gironacci
    • Year: 2022
    • Citations: 4
  10. ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors
    • Authors: A.E. Portales, E.R. Mustafá, C.I. McCarthy, M. Perelló, J. Raingo
    • Year: 2022
    • Citations: 8